← SynDRA
PF-04995274
SynDRA canonical compound SYN0033966 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HTR4 |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- serotonin receptor agonist
- HTR4 AGONIST
Cross-references
Synonyms
- PF 04995274
- UNII-XI179PG9LV
- XI179PG9LV
- CHEMBL2152922
- (R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol
- PF04995274
- compound 2d [PMID: 22974325]
- SCHEMBL619629
- GTPL9059
- WLLOFQROROXOMO-GOSISDBHSA-N
- ZINC95577747
- BDBM50398598
- DB12675
- NCGC00386746-01
- PF-04995274, >
- 4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol
- compound 2d (PMID: 22974325)
- RefChem:172239
- orb1307903
- SCHEMBL29385310
- EX-A4112
- GDC78227
- MFCD29079009
- AKOS040742393
- AT25183
- EBC-384061
- AC-30621
- DA-76764
- HY-18137
- MS-27716
- CS-0007316
- NS00073067
- S0496
- PF-04995274?
- T16481
- PF-04995274, >=98% (HPLC)
Look up PF-04995274 in the interactive SynDRA portal →